cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Evelo Biosciences Inc
9 own
13 watching
Current Price
$0
$0
(-2.06%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
12.91M
52-Week High
52-Week High
3.29
52-Week Low
52-Week Low
0.0243
Average Volume
Average Volume
0.36M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization12.91M
icon52-Week High3.29
icon52-Week Low0.0243
iconAverage Volume0.36M
iconDividend Yield--
iconP/E Ratio--
What does the Evelo Biosciences Inc do?
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hyperinflammatory response associated with COVID-19. The company also develops EDP1867, an inactivated investigational oral biologic, which is in Phase 1b for the treatment of inflammatory diseases; EDP2939, an extracellular vesicle investigational oral biologic for the treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Read More
How much money does Evelo Biosciences Inc make?
News & Events about Evelo Biosciences Inc.
Ticker Report
2 months ago
Evelo Biosciences (NASDAQ:EVLO Get Rating) had its target price lowered by BMO Capital Markets from $10.00 to $5.00 in a research note released on Friday morning, The Fly reports. Several other research firms have also issued reports on EVLO. Jefferies Financial Group lowered shares of Evelo...
Globe Newswire
2 months ago
CAMBRIDGE, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO), (Evelo or the Company) a clinical stage biotechnology company developing a novel platform of orally delivered inflammation-resolving medicines acting on the small intestinal axis, SINTAX, today reported ...
Zolmax
5 months ago
Evelo Biosciences, Inc. (NASDAQ:EVLO Get Rating) was the target of unusually large options trading activity on Wednesday. Investors bought 1,885 put options on the company. This is an increase of approximately 1,101% compared to the typical daily volume of 157 put options. Wall Street Analyst Weigh ...
Ticker Report
5 months ago
Evelo Biosciences, Inc. (NASDAQ:EVLO Get Rating) was the target of unusually large options trading activity on Wednesday. Investors bought 1,885 put options on the company. This is an increase of approximately 1,101% compared to the typical daily volume of 157 put options. Wall Street ...
Globe Newswire
5 months ago
CAMBRIDGE, Mass., Dec. 16, 2022 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a novel platform of orally delivered medicines acting on the small intestinal axis, SINTAX, today announced it has entered into a senior secured loan agreement...
Frequently Asked Questions
Frequently Asked Questions
What is Evelo Biosciences Inc share price today?
plus_minus_icon
Can Indians buy Evelo Biosciences Inc shares?
plus_minus_icon
How can I buy Evelo Biosciences Inc shares from India?
plus_minus_icon
Can Fractional shares of Evelo Biosciences Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Evelo Biosciences Inc stocks?
plus_minus_icon
What is today’s traded volume of Evelo Biosciences Inc?
plus_minus_icon
What is today’s market capitalisation of Evelo Biosciences Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Evelo Biosciences Inc?
plus_minus_icon
What percentage is Evelo Biosciences Inc down from its 52-Week High?
plus_minus_icon
What percentage is Evelo Biosciences Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$0
(-2.06%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00